1. Home
  2. YRD vs INKT Comparison

YRD vs INKT Comparison

Compare YRD & INKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Yiren Digital Ltd.

YRD

Yiren Digital Ltd.

N/A

Current Price

$0.36

Market Cap

62.5M

Sector

Finance

ML Signal

N/A

Logo MiNK Therapeutics Inc.

INKT

MiNK Therapeutics Inc.

N/A

Current Price

$9.82

Market Cap

53.7M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
YRD
INKT
Founded
2012
2017
Country
China
United States
Employees
N/A
N/A
Industry
Finance: Consumer Services
Medicinal Chemicals and Botanical Products
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
62.5M
53.7M
IPO Year
2015
2021

Fundamental Metrics

Financial Performance
Metric
YRD
INKT
Price
$0.36
$9.82
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
★ $42.50
AVG Volume (30 Days)
★ 2.4M
9.6K
Earning Date
11-24-2026
11-11-2026
Dividend Yield
N/A
N/A
EPS Growth
★ N/A
N/A
EPS
★ N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$425.24
N/A
Revenue Next Year
N/A
$44.74
P/E Ratio
$1.86
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.36
$8.48
52 Week High
$5.60
$15.27

Technical Indicators

Market Signals
Indicator
YRD
INKT
Relative Strength Index (RSI) 26.97 49.37
Support Level $0.36 $9.05
Resistance Level $1.05 $12.27
Average True Range (ATR) 0.05 0.82
MACD -0.02 0.06
Stochastic Oscillator 1.10 61.25

Price Performance

Historical Comparison
YRD
INKT

About YRD Yiren Digital Ltd.

Yiren Digital Ltd is an AI-powered platform providing a comprehensive suite of financial and lifestyle services in China. Its mission is to elevate customers' financial well-being and enhance their quality of life by delivering digital financial services, tailor-made insurance solutions, and premium lifestyle services. The company supports clients at various growth stages, addressing financing needs arising from consumption and production activities, while aiming to augment the overall well-being and security of individuals, families, and businesses.

About INKT MiNK Therapeutics Inc.

MiNK Therapeutics Inc is a clinical-stage biopharmaceutical company pioneering the discovery, development and manufacturing of allogeneic, off-the-shelf, invariant natural killer T (iNKT) cell therapies to treat cancer and other immune-mediated diseases. iNKT cells offer distinct therapeutic advantages as a platform for allogeneic therapy in that the cells naturally home to tissues, aid clearance of tumors and infected cells, and suppress graft-versus-host-disease. Its product candidate, agenT-797, is an off-the-shelf, allogeneic, native iNKT cell therapy. It operates its business in single segment.

Share on Social Networks: